NCT01905722View on ClinicalTrials.gov

Development of Novel Therapies for NIDDM

NACompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

December 10, 2013

Primary Completion Date

May 17, 2017

Study Completion Date

May 17, 2017

Conditions
Metabolism
Interventions
OTHER

3 Tesla

3 Tesla scanning with intravenous infusion of tracers

OTHER

7 Tesla

7 Tesla scanning with intravenous infusion of tracers

Trial Locations (1)

75390

University of Texas Southwestern Medical Center, Dallas

Sponsors

Lead Sponsor

Duke University
All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

collaborator

University of Texas Southwestern Medical Center

OTHER

lead

Duke University

OTHER

NCT01905722 - Development of Novel Therapies for NIDDM | Biotech Hunter | Biotech Hunter